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High-density lipoprotein and its major protein constituent
apolipoprotein A-I suppress intestinal inﬂammation in vitro
and in vivo via activation of the autophagic pathway.
BACKGROUND & AIMS: Plasma levels of high-density lipo-
protein (HDL) cholesterol are frequently found decreased in
patients with inﬂammatory bowel disease (IBD). Therefore, and
because HDL exerts anti-inﬂammatory activities, we investi-
gated whether HDL and its major protein component apolipo-
protein A-I (apoA-I) modulate mucosal inﬂammatory responses
in vitro and in vivo.
METHODS: The human intestinal epithelial cell line T84 was
used as the in vitro model for measuring the effects of HDL on
the expression and secretion of tumor necrosis factor (TNF),
interleukin-8 (IL-8), and intracellular adhesion molecule
(ICAM). Nuclear factor-kB (NF-kB)-responsive promoter activ-
ity was studied by dual luciferase reporter assays. Mucosal
damage from colitis induced by dextran sodium sulphate (DSS)
and 2,4,6-trinitrobenzenesulfonic acid (TNBS) was scored by
colonoscopy and histology in apoA-I transgenic (Tg) and apoA-I
knockout (KO) and wild-type (WT) mice. Myeloperoxidase
(MPO) activity and TNF and ICAM expression were determined
in intestinal tissue samples. Autophagy was studied by Western
blot analysis, immunoﬂuorescence, and electron microscopy.
RESULTS: HDL and apoA-I down-regulated TNF-induced mRNA
expression of TNF, IL-8, and ICAM, as well as TNF-induced NF-
kB-responsive promoter activity. DSS/TNBS-treated apoA-I KO
mice displayed increased mucosal damage upon both colonos-
copy and histology, increased intestinal MPO activity and
mRNA expression of TNF and ICAM as compared with WT and
apoA-I Tg mice. In contrast, apoA-I Tg mice showed less severe
symptoms monitored by colonoscopy and MPO activity in both
the DSS and TNBS colitis models. In addition, HDL induced
autophagy, leading to recruitment of phosphorylated IkB kinase
to the autophagosome compartment, thereby preventing NF-kB
activation and induction of cytokine expression.
CONCLUSIONS: Taken together, the in vitro and in vivo ﬁnd-
ings suggest that HDL and apoA-I suppress intestinal inﬂam-
mation via autophagy and are potential therapeutic targets forthe treatment of IBD. (Cell Mol Gastroenterol Hepatol 2015;
1:171–187; http://dx.doi.org/10.1016/j.jcmgh.2014.12.006)
Keywords: Apolipoprotein A-I; Autophagy; Inﬂammatory Bowel
Disease; NF-kB.
igh-density lipoproteins (HDL) are particlesHcomposed of proteins and lipids synthesized by the
liver and the intestine. In addition to mediating reverse
transport of cholesterol from macrophages to the liver,1–4
HDL performs many anti-inﬂammatory activities.5–7
Whereas the reverse cholesterol transport-function of HDL
has become the classic explanation for the inverse associa-
tion between HDL cholesterol levels and cardiovascular risk,
both the mechanisms and the consequences of its anti-
inﬂammatory properties are less well understood. In an
in vivo model of intestinal inﬂammation, colonoscopy and
histology showed increased mucosal damage and inﬂam-
mation in apolipoprotein A-I (apoA-I) knockout (KO) mice,
which lack HDL. In contrast, transgenic (Tg) mice over-
expressing human apoA-I, which has very high plasma levels
of HDL, were protected from intestinal inﬂammation. In
cultivated enterocytes, both HDL and its major protein
component apoA-I down-regulated the expression of
proinﬂammatory cytokines in vitro via a nuclear factor-kB
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the expression of light chain 3 II (LC3II), an autophagosomal
membrane-bound protein, through the inhibition of mTOR,
the mammalian target of rapamycin, and induced auto-
phagy. HDL-induced autophagy led to the recruitment of
phosphorylated IkB kinase (p-IKK, which mediates NF-kB
activation) to the autophagosome compartment, thereby
preventing further NF-kB activation and induction of cyto-
kine expression. Inhibition of autophagy reversed the sup-
pressive effect of HDL on inﬂammation. Thus, HDL and its
major protein component apolipoprotein A-I (apoA-I) act in
an anti-inﬂammatory manner via induction of autophagy
and subsequent recruitment of p-IKK to the autophagosome
compartment. The clinical exploitation of HDL could be
signiﬁcant for the treatment of inﬂammatory diseases such
as inﬂammatory bowel disease (IBD).
HDL encompasses a heterogeneous class of plasma
lipoproteins, which contain apoA-I as the main protein, and
phospholipids and cholesterol as the main lipids. HDL par-
ticles as well as apoA-I exert various anti-inﬂammatory,
antioxidative, and cytoprotective effects in vitro and
in vivo, which are thought to confer protection against
chronic inﬂammatory disorders.8,9 A low plasma concen-
tration of HDL cholesterol is a risk factor for cardiovascular
disease, diabetes mellitus, and certain cancers.10–15
The intestine and liver are the major organs responsible
for HDL synthesis. Dysfunction of either of these organs as a
result of inﬂammation is associated with a decrease in
plasma levels of HDL cholesterol and apoA-I.16,17 For
example, HDL cholesterol levels are signiﬁcantly decreased
in patients with active IBD.18,19 Traditionally, it was thought
that low levels of HDL cholesterol in IBD patients are a
consequence of the disorder; however, due to the well-
known anti-inﬂammatory effects of HDL, we hypothesized
that HDL and apoA-I might in fact modulate intestinal
inﬂammation in such patients. Having established the anti-
inﬂammatory effects of HDL and apoA-I in the intestine,
we further hypothesized that autophagy plays a role in
this process as earlier studies had shown an uptake of
HDL into intracellular compartments now identiﬁed as
autophagosomes.20
Materials and Methods
Cell Cultures
Human colon-derived epithelial cell line T84 cells were
cultured in Dulbecco’s modiﬁed Eagle’s medium 12 (Invi-
trogen, Basel, Switzerland) in a humidiﬁed atmosphere
containing 5% CO2 at 37C. The medium was supplemented
with 10% fetal bovine serum (Bruschwig, Basel,
Switzerland) and penicillin/streptomycin (100 mg/mL/100
mg/mL) (Invitrogen).
Isolation of High-Density Lipoprotein and
Apolipoprotein A-I from Plasma
Human HDL (1.063<d<1.21 kg/L) was isolated from the
plasma of normolipidemic blood donors by sequential ul-
tracentrifugation.21 Purity was conﬁrmed using sodium
dodecyl sulfate polyacrylamide gel electrophoresis and bythe presence of apoA-I and the absence of low-density
lipoprotein, apolipoprotein B, and albumin. ApoA-I was
puriﬁed from delipidated HDL by fast protein liquid
chromatography.22
RNA Isolation, Reverse Transcription, and
Real-Time Polymerase Chain Reaction
The T84 cells were incubated with HDL 50–200 mg/mL
for 18 hours and then with tumor necrosis factor (TNF) 25
ng/mL for 3 hours. Total RNA was isolated using TRIzol
reagent (Invitrogen). We reverse transcribed 1–2 mg RNA
with a High-Capacity cDNA Reverse Transcription Kit
(Applied Biosystems, Rotkreuz, Switzerland) before real-
time polymerase chain reaction (RT-PCR) analysis
(7900HT; Applied Biosystems) using various TaqMan as-
says: Hs00174128_m1 (human TNF), Mm00443258_m1
(murine TNF), Hs00174103_m1 (human interleukin-8 [IL-
8]), Hs00164932_m1 (human intracellular adhesion mole-
cule [ICAM]), Mm00516023_m1 (murine ICAM),
Hs00222677_m1 (human b-actin), 4352341E_mACTB (mu-
rine b-actin), Hs00797944_s1 (LC3), Hs00250530_m1
(ATG16L1), and endogenous controls for human and ani-
mals (Applied Biosystems). Constitutively expressed b-actin
was measured as an internal standard for normalization.
Relative mRNA levels were calculated using the comparative
threshold cycle method. For each experiment, all tests were
performed in triplicate. The mRNA levels obtained in control
conditions were set to 1, and the results are shown relative
to those.
Luciferase Reporter Assays
Cells were cotransfected with the luciferase reporter
constructs of NF-kB (400 ng) and the expression plasmids
pTAL-luc (200 ng) at a ratio of 3 mg FuGENE HD per 1 mg
DNA. The pcDNA33.1(þ) vector was added to normalize the
amount of DNA transfected, where necessary. We cotrans-
fected 100 ng of the Renilla luciferase (pRL-CMV) reporter
plasmid (Promega, Dübendorf, Switzerland) to assess
transfection efﬁciency. Cells were harvested 36 hours after
transfection, and luciferase activity was determined using
the Dual Luciferase Assay System (Promega) and a Lumi-
noskan Ascent Microplate Luminometer (Thermo Fisher
Scientiﬁc, Wohlen, Switzerland). Reporter activities ob-
tained from the empty pGL3basic corresponding to each test
condition and for the test construct containing the test
promoter in the control conditions were set to 1, and fold
activities were shown relative to this. All experiments were
performed in triplicate and repeated at least three times.
Electrophoretic Mobility Shift Assays
Oligonucleotides with 5-GATC overhangs were used for
annealing NF-kB consensus (top strand, 5-GATCAGTT
GAGGGGACTTTCCCAGGC-3; bottom strand, 5-GATCGCCTGG
GAAAGTCCCCTCAACT) for radioactive labeling by ﬁll-in
reactions as described by Saborowski et al.23 Protein
(5 mg) from nuclear extracts prepared by using the NE-PER
extraction kit (Pierce, Lausanne, Switzerland) were mixed
with 50,000 cpm (1.0 ng) of the radioactive probe, and
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nutes at 30C. In supershift experiments, 1 mg of the anti-
NF-kB p65 antibody (C-20; Santa Cruz Biotechnology, Santa
Cruz, CA) was added to the extracts before binding reactions
and incubated at 4C for 1 hour before the addition of
radioprobes. The electrophoretic mobility shift assay
(EMSA) gels were run at 200V in 0.5X Tris-borate-ethylene-
diamine-tetraacetic acid (EDTA) and processed as described
for autoradiography.23Animals
Female wild-type (WT) (C57BL/6J) mice, apoA-I
knockout (KO) (B6.129P2-ApoA-Itm1Unc/J [–/–]) mice,
and apoA-I Tg (C57BL/6-Tg [ApoA-I]1Rub/J) mice (all 7–8
weeks old) were used. The animals, which were purchased
from the Jackson Laboratory (Bar Harbor, ME), were
housed in a speciﬁed pathogen-free facility in individually
ventilated cages. For the dextran sodium sulphate (DSS)
model, colitis was induced with drinking water containing
2.5% of DSS (MP Biomedicals, Illkirch, France).24 The an-
imals were divided into six groups: three DSS groups and
three DSS-free water control groups (with six mice in each
group). Animals were fed food and water with or without
DSS ad libitum; 24 hours before animals were sacriﬁced,
DSS groups were fed with water without DSS.
For the 2,4,6-trinitrobenzenesulfonic acid (TNBS) model,
colitis was induced with TNBS (Fluka/Sigma-Aldrich
Chemie Gmbh, Munich, Germany) with ﬁve mice in each
group. Brieﬂy, on day 1, mice were shaved between the
shoulders, and 150 mL of TNBS presensitization solution
(ﬁnal concentration 1% in ethanol/acetone/olive oil) was
applied to the abdominal skin. On day 8, 100 mL of TNBS
solution (ﬁnal concentration 2.5% in 50% ethanol) was
slowly administered into the colon 4 cm proximal to the
anus with a 3.5F catheter to a 1 ml syringe. The catheter was
gently removed from the colon, and the mouse was kept
with the head down in a vertical position for 60 seconds.
Mice were sacriﬁced on day 18.25 All the animal experi-
ments were approved by the veterinary authorities of Zur-
ich, Switzerland, and were performed according to Swiss
animal welfare laws.Determination of Colonoscopy and Total
Histologic Score
Macroscopic mucosal damage was assessed by colonos-
copy scoring using the murine endoscopic index of colitis
severity (MEICS), monitored by a miniendoscope. Animals
were anesthetized intraperitoneally with a mixture of ke-
tamine, 90–120 mg/kg body weight (Vétoquinol, Bern,
Switzerland), and xylazine, 8 mg/kg body weight (Bayer,
Lyssach, Switzerland), and were examined as described
previously elsewhere.26–28 The endoscope was introduced
with a lubricant (2% lidocaine) through the anus in the
sedated mouse, the colon was gently inﬂated with air, and
photographs were taken. Recording was performed with the
Karl Storz Tele Pack Pal 20043020 (Karl Storz Endoskope,
Tuttlingen, Germany).The MEICS was scored based on mucosal bleeding,
abundant ﬁbrin, altered vascular pattern, nontransparent
mucosa (granularity), and stool composition as described by
Becker et al.26 Colonoscopy was performed on day 8 before
sacriﬁcing the mice. From the distal third of the colon, 1 cm
of colonic tissue was removed, washed with saline buffer,
and ﬁxed in 4% formalin overnight. Sections of the parafﬁn-
embedded tissue were used for histologic analysis, as
described previously elsewhere, based on loss of crypts, loss
of goblet cells, inﬁltration of lymphocytes, and thickening of
submucosa/mucosa.25,26 The histologic examination was
performed by two independent, blinded investigators.
Isolation and Culture of Human Colonic Lamina
Propria Fibroblasts
Primary human colonic lamina propria ﬁbroblast cul-
tures were derived from surgical specimens of patients with
active Crohn’s disease and were cultured as described
previously elsewhere.29 Fibroblasts were cultured in Dul-
becco’s modiﬁed Eagle’s medium containing 10% fetal calf
serum, penicillin 100 IU/mL, streptomycin 100 mg/mL,
ciproﬂoxacin 8 mg/mL, gentamicin 50 mg/mL, and ampho-
tericin B 1 mg/mL. Genomic DNA was isolated from cultured
ﬁbroblasts and genotyped for the ATG16L1 variant using
predesigned genotyping assays (Applied Biosystems, Foster
City, CA) and TaqMan technology. Written informed consent
was obtained before specimen collection, and the studies
were approved by the local ethics committee.
Gold Labeling of High-Density Lipoprotein
Colloidal gold was prepared as described previously
elsewhere30 using a particle size of 8 nm. For the conjuga-
tion of HDL to colloidal gold, 10 mL of a monodisperse gold
solution was added to a 16-mL lipoprotein solution con-
taining 50 mg of lipoprotein per milliliter in a phosphate
buffer at pH 5.5. Excess lipoprotein was removed by
centrifugation at 9000 g for 20 minutes against glycerine
and then dialyzed in Tris-borate-ethylene-diamine-
tetraacetic acid (EDTA) buffer to remove the glycerine.
To follow the uptake of HDL into the intestinal cell line,
colon carcinoma HT29 cells were incubated with gold-
labeled HDL for 18 hours. The cells were washed in
phosphate-buffered saline (PBS) and ﬁxed with 2.5%
glutaraldehyde þ 0.8% formaldehyde in NaCL 50 mM and
phosphate buffer 0.1 M for 2 hours at room temperature,
postﬁxed in 1% OsO4 (phosphate buffer 50 mM) at 4C for 1
hour, and block stained with 1% uranyl acetate in water for
1 hour. Thereafter, the tissue was dehydrated in ethanol
(70%–100%, 30 minutes) and propylene oxide (two times
20 minutes), polymerized, and embedded in Epon Araldite.
Electron microscopy was performed on a Philips CM100
transmission electron microscope (Philips, Eindhoven, the
Netherlands).
Transfection of Cells with Small Interfering RNAs
Cells were seeded at a density of 400,000 cells/well
onto 24-well plates and transfected with LC3 siGenome
SMARTpool (Dharmacon, Lafayette, CO) or siCONTROL
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con) at a ﬁnal concentration of 50 nM using the TransIT-
TKO reagent (Mirus Bio LLC, Madison, WI). The
transfections were repeated after 24 hours, and the cells
were harvested in 1 mL TRIzol (Invitrogen) 24 hours after
the second transfection.Western Blotting
Cells were grown on six-well plates for 24 hours, fol-
lowed by incubation with HDL for 18 hours before treat-
ment with 25 ng/mL TNF for 3 hours where indicated. Cells
were harvested into radioimmune precipitation assay buffer
with protease inhibitors. The cell debris was removed by
centrifugation, and the supernatants were denatured at
94C. We subjected 20 mg of protein to electrophoresis,
which was then blotted onto a nitrocellulose membrane.
Immunodetection was performed using anti-phospho-IKKa,
anti-phospho mTOR, anti-mTOR (all from Cell Signaling
Technology, Beverly, MA), anti-LC3 (Sigma-Aldrich, St. Louis,
MO), and anti-actin (Millipore, Billerica, MA) where indi-
cated. The bands were visualized using the electro-
chemiluminescence system, and densitometry of bands was
measured using ImageJ (http://imagej.nih.gov/ij/).Confocal Microscopy
After treatment of cells with HDL for 18 hours and TNF
for 3 hours, the cells were washed with PBS and ﬁxed with
4% paraformaldehyde (PFA) for 15 minutes. For LC3
staining, ﬁxed cells were washed with PBS, permeabilized
in 100% methanol at –20C for 10 minutes, washed with
PBS, and blocked with 3% bovine serum albumin for 1
hour at room temperature. Cells were subsequently
incubated with LC3/p-IKK antibody (1:200 dilution; Cell
Signaling Technology) overnight at 4C. After 3 PBS-
Tween washes, cells were incubated with Alexa 488 con-
jugated secondary rabbit antibody (Invitrogen) for 1 hour
at room temperature and then washed three times in Tris-
buffered saline with Tween before mounting with antifade
medium (Dako, Glostrup, Denmark). Cells were analyzed
by confocal microscopy in a Leica SP5 laser scanning
confocal microscope (Leica Microsystems, Wetzlar, Ger-
many) using a Zeiss AxioCam HRm CCD camera, and Zeiss
EC Plan-Neoﬂuar 10/0.3 and Zeiss LD Plan-Neoﬂuar
20/0.4 objectives (Carl Zeiss Microscopy GmbH, Jena,
Germany). After sequential excitation, green and blue
ﬂuorescent images of the same sample were acquired and
processed using Leica confocal software (LAS-AF Lite;
Leica Microsystems).
Results
Anti-inﬂammatory Effect of High-Density
Lipoprotein and Apolipoprotein A-I In Vivo
Intestinal Inﬂammation Is Ameliorated in Apolipo-
protein A-I Transgenic Mice with Dextran Sodium
Sulphate Colitis. Upon application of DSS to the drinking
water of WT, apoA-I KO, and human apoA-I Tg mice, ani-
mals experienced mucosal damage of the intestine andcolon but of different severity. The apoA-I Tg mice, which
have strongly elevated plasma levels of HDL cholesterol,
displayed an intact epithelial surface with still-formed
stools compared with the WT mice. In contrast, a severe
disruption of the epithelium was observed in the apoA-I
KO mice (Figure 1A), which are HDL deﬁcient. A histo-
logic analysis of distal colon tissue samples showed that,
upon DSS treatment, the apoA-I KO mice had severe bar-
rier breakdown with extensive inﬁltration reaching the
lamina muscularis mucosae, and the total histologic
score was signiﬁcantly increased for apoA-I KO mice
(Figure 1B).
Weight loss was monitored during the 7-day course of
acute colitis. Upon treatment with DSS and in comparison
with the DSS-free-water control animals, the body weight
decreased signiﬁcantly in the WT mice and apoA-I KO mice
but not in the apoA-I Tg mice (Figure 1C). Tissue homoge-
nates of DSS-treated apoA-I Tg mice showed signiﬁcantly
lower myeloperoxidase (MPO) activity than the DSS-treated
apoA-I KO mice and WT mice (Figure 1D). Finally, DSS
supplementation led to a signiﬁcant increase in mRNA
expression of TNF and ICAM in the whole colon tissue in all
animals, but the expression of TNF and ICAM in apoA-I KO
mice was 18 and 34 times higher, respectively, than in the
WT mice, and 10 and 168 times higher, respectively, than in
the apoA-I Tg mice (Figure 1E).
Intestinal Inﬂammation Is Ameliorated in Apo-
lipoprotein A-I Transgenic Mice with 2,4,6-
Trinitrobenzenesulfonic Acid Colitis. Upon
administration of TNBS to the WT, apoA-I KO, and human
apoA-I Tg mice, the animals experienced mucosal damage
of the intestine and colon but of different severity. Upon
TNBS-induced colitis, weight loss in the apoA-I KO mice
was signiﬁcantly higher as compared with the apoA-I Tg
mice during the last 2 days before the animals were
sacriﬁced (Figure 2A). The macroscopic mucosal damage
was assessed by colonoscopy and MEICS. On day 2 after
TNBS administration into the colon mucosa, the apoA-I Tg
mice displayed a smooth and transparent mucosa with a
normal vascular pattern compared with the opaque mucosa
with altered vascular pattern in the apoA-I KO mice. On day
9 after TNBS administration, the colon of the apoA-I Tg
mice appeared to be less transparent. In the apoA-I KO
mice, the colon appeared with a thickened, more granular
mucosa and a clearly altered vascular pattern. The apoA-I
KO animals were given a signiﬁcantly higher MEICS score
compared with the apoA-I Tg mice (Figure 2B). Also on a
microscopic level for the apoA-I KO mice, a more severe
colitis was found compared with the apoA-I Tg mice. The
total histologic score for the apoA-I KO mice with induced
TNBS colitis was increased compared with the apoA-I Tg
mice (Figure 2C).Anti-inﬂammatory Effect of High-Density
Lipoprotein and Apolipoprotein A-I in Vitro
A series of in vitro experiments in the colonic epithelial
cell line T84 were performed to further elucidate the
mechanism of the effects found in vivo. These experiments
Figure 1. Intestinal inﬂammation is ameliorated in apolipoprotein A-I transgenic (apoA-I Tg) mice upon colitis induced
with dextran sodium sulphate (DSS). (A) Miniendoscopy showed severe disruption of the epithelium in apoA-I knockout (KO)
mice receiving DSS. Macroscopic mucosal damage was assessed by colonoscopy scoring (murine endoscopic index of colitis
severity). Each bar represents the mean ± standard error of the mean (SEM); n ¼ 6; *P < .05, ***P < .001. (B) H&E staining of
sections from apoA-I KO mice receiving DSS displayed severe barrier breakdown with extensive inﬁltration reaching the lamina
muscularis mucosae. The total histologic score, calculated as the sum of the epithelium and inﬁltrate score, was plotted. Each
bar represents themean±SEM; n¼ 6; *P< .05, **P< .01. (C) Weight losswasmonitored during the 7-day course of acute colitis.
Upon treatment with DSS and in comparisonwith the DSS-free-water control animals, the bodyweight decreased signiﬁcantly in
wild-type (WT) and apoA-I KOmice (P< .001) but not in apoA-I Tgmice. (D) Tissue homogenates of DSS-treated apoA-I Tgmice
showed signiﬁcantly lower myeloperoxidase (MPO) activity than the DSS-treated apoA-I KO and WTmice ***P < .001. (E) Upon
DSS-induced colitis, apoA-I KO mice receiving DSS displayed a signiﬁcant increase in mRNA expression of tumor necrosis
factor (TNF) and intracellular adhesion molecule (ICAM), whereas apoA-I Tg mice displayed lower expression levels of TNF and
ICAM compared with WT and apoA-I KO mice. The mRNA expression was calculated relative to WT mice receiving DSS-free
water. Each bar represents the mean ± SEM; n ¼ 6; ***P < .001).
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Figure 1. (continued).
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expression of proinﬂammatory cytokines via a NF-kB-
dependent pathway. The mRNA expression of TNF, IL-8,
and ICAM was quantiﬁed in T84 cells in the presence or
absence of HDL. The T84 cells were incubated with 200 mg
HDL for 18 hours and then stimulated with 25 ng/mL TNF
for 3 hours. TNF signiﬁcantly induced the mRNA expres-
sion of TNF, IL-8, and ICAM by factors of 178, 127, and 830,
respectively, whereas HDL pretreatment signiﬁcantly
suppressed this expression by 59%, 31%, and 50%,
respectively (Figure 3A). The suppressive effect of HDL on
TNF-induced mRNA expression of TNF was concentration
dependent, ranging from 20% in the presence of 50 mg/mL
HDL to 60% in the presence of 200 mg/mL HDL
(Figure 3B).
Lipid-free apoA-I mimicked these anti-inﬂammatory
effects of HDL, pointing to an important role of apoA-I in
this process. Incubation of T84 cells with 100 mg/mL apoA-I
for 18 hours before the addition of 25 mg/mL TNF for 3hours led to a decrease in TNF-induced mRNA expression of
TNF, IL-8, and ICAM by 73%, 54%, and 51%, respectively
(Figure 3C); the suppressive effect of apoA-I on the
TNF-induced mRNA expression of TNF was concentration
dependent (Figure 3D).
The down-regulation of proinﬂammatory cytokines by
HDL and apoA-I occurred via a NF-kB-dependent pathway.
Immunoblotting showed that when cells were pretreated
with HDL for 18 hours and then stimulated for 3 hours with
25 ng/mL TNF, the phosphorylation of the IkB kinase
complex (p-IKK), a process that precedes the translocation
of NF-kB to the nucleus, was slightly decreased by HDL.
Pretreatment of the cells with TNF increased p-IKK by 46%;
however, this effect was reduced by 70% in the presence of
HDL (Figure 3E).
Next, tests were performed to determine whether HDL
suppresses TNF-induced NF-kB responsive promoter activ-
ity. The T84 cells were transiently transfected with lucif-
erase constructs expressing an NF-kB responsive element.
Figure 2. Intestinal in-
ﬂammation is amelio-
rated in apolipoprotein
A-I transgenic (apoA-I Tg)
mice with colitis induced
by 2,4,6-trinitrobenzene-
sulfonic acid (TNBS). (A)
Percentage body weight
loss showed an increase in
body weight in apoA-I
Tg mice compared with
apoA-I knockout (KO) mice
at days 9 and 10 after
TNBS administration into
the colon (± standard error
of the mean [SEM], n ¼ 5
each, *P < .05). (B) Mini-
endoscopy showed a
clearly altered vascular
pattern in apoA-I Tg mice
receiving TNBS compared
with both apoA-I KO and
wild-type (WT) mice.
Macroscopic mucosal da-
mage was assessed by
colonoscopy scoring (mu-
rine endoscopic index of
colitis severity) (± standard
deviation [SD], n ¼ 5 each,
*P < .05). (C) H&E staining
of sections from apoA-I
KO mice receiving TNBS
displayed barrier break-
down with inﬁltration. The
total histologic score, cal-
culated as the sum of the
epithelium and inﬁltrate
score, was plotted. Each
bar represents the mean ±
SD; n ¼ 5.
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HDL for 18 hours and then 25 ng/mL TNF for 6 hours. HDL
signiﬁcantly inhibited NF-kB luciferase activity (by 26%).
Treatment with TNF alone almost tripled luciferase activity,
but preconditioning with HDL or lipid-free apoA-I signiﬁ-
cantly suppressed this effect (both by 50%; Figure 3F).
Nuclear extracts from T84 cells were subjected to EMSA.
This showed that pretreatment of the T84 cells with HDLor apoA-I decreased TNF-induced binding of NF-kB to a
32P-labeled consensus NF-kB binding DNA sequence
(Figure 3G).
High-Density Lipoprotein Induces Autophagy
and Is Taken Up into Autophagosomes
Autophagy increases cell survival during periods of
stress via catabolism of subcellular proteins, organelles, and
Figure 3. Anti-inﬂammatory effect of high-density lipoprotein (HDL) and apolipoprotein A-I (apoA-I) in vitro. (A) HDL
suppressed tumor necrosis factor (TNF)-induced mRNA expression of TNF, interleukin-8 (IL-8), and intracellular adhesion
molecule (ICAM). The mRNA expression of TNF, IL-8, and ICAM was quantiﬁed by reverse-transcriptase real-time polymerase
chain reaction (RT-PCR) and normalized to actin. Results represent mean ± standard deviation (SD), n ¼ 3, ***P < .001. (B)
HDL suppressed TNF-induced mRNA expression of TNF in a concentration-dependent manner. The mRNA expression
of TNF was quantiﬁed by RT-PCR and normalized to actin. Each bar represents the mean ± standard deviation (SD), n ¼ 3,
***P < .001. (C) ApoA-I (similar to HDL) suppressed mRNA expression of TNF, IL-8, and ICAM. The mRNA expression of TNF,
IL-8, and ICAM was quantiﬁed by RT-PCR and normalized to actin. The results represent the mean ± SD, n ¼ 3, ***P < .001. (D)
ApoA-I suppressed TNF-induced mRNA expression of TNF in a concentration-dependent manner. The mRNA expression of
TNF was quantiﬁed by RT-PCR and normalized to actin. Each bar represents the mean ± SD, n ¼ 3, ***P < .001. (E) HDL
decreased the phosphorylation of IkB kinase (p-IKK). The p-IKK arbitrary units represent the ratio of p-IKK to actin normalized
to the untreated controls. (F) HDL and apoA-I suppressed TNF-induced NF-kB-responsive promoter activity. *P < .05, ***P <
.001. (G) HDL and apoA-I decreased the TNF-induced NF-kB DNA binding activity. The top arrow indicates the binding re-
action of TNF to the NF-kB consensus, and the bottom arrow shows the supershift observed upon incubation of nuclear
extracts with the anti-p65 antibody.
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Figure 3. (continued).
March 2015 Role of HDL Via IkB Kinase Autophagy 179cytoplasmic components that generate free fatty acids,
amino acids, and nucleotides.31–33 Autophagy is critically
involved in regulating innate immune responses by
providing a defence against intracellular microbial patho-
gens and mediating antigen presentation via MHC class-II
molecules.34,35 Dysfunctional autophagy is associated with
defective bacterial handling, prolonged intracellular survival
of pathogens, and uncontrolled inﬂammation. Autophago-
somes are characterized by double membrane vesicles, theformation of which is mediated by autophagy proteins
such as ATG12-ATG5-ATG16 and a microtubule associated
protein light chain 3 (LC3). Increase in autophagy can
be characterized by conversion of LC3-I to the
phosphatidylethanolamine-conjugated form of LC3II that
accumulates on autophagic vesicles.36,37 Levels of auto-
phagy proteins, such as ATG16L1 or IRGM, are signiﬁcantly
decreased in the intestine of Crohn’s disease (CD) pa-
tients.38 To date, three autophagy genes have been
180 Gerster et al Cellular and Molecular Gastroenterology and Hepatology Vol. 1, No. 2conﬁrmed as CD susceptibility genes, namely, ATG16L1,
IRGM, and Leucine-rich repeat kinase 2 (LRRK2).
An uptake of HDL into vesicles that retrospectively
appear to be autophagosomes has already been reported in
1992.20 We therefore investigated whether the HDL/apoA-I
mediated anti-inﬂammatory effect could be associated with
autophagy. Incubation of T84 cells with HDL stimulated
autophagy, as demonstrated by a signiﬁcant increase in
punctate staining for LC3. The T84 cells were treated with
0 or 100 mg/mL HDL for 18 hours, then ﬁxed with 4% PFA,
and stained for LC3 (green) or cell nuclei (40,6-diamidino-2-
phenylindole [DAPI, blue]). An increase in punctate
staining—representing LC3 protein accumulation (ie, auto-
phagosome formation)—was observed in the cells incu-
bated with HDL (Figure 4A). Incubation of the T84 cells with
HDL also led to increased conjugation of the cytosolic pro-
tein LC3I to the autophagosomal membrane-bound LC3II
during autophagy. This was demonstrated by an increase in
the LC3II:LC3I ratio after the incubation of T84 cells withincreasing concentrations of HDL for 18 hours, conﬁrmed by
Western blot analysis and immunoﬂuorescence analysis of
whole cell protein extracts with anti-LC3 antibodies. The
increase was concentration dependent, and LC3 II expres-
sion was maximum at 18 hours (Figure 4B).
The HDL-induced increase in LC3II was found to be
mediated via inhibition of mTOR, a negative regulator
of autophagy. T84 cells were treated with 50 mg HDL
for 18 hours, and whole cell protein extracts were
analyzed by Western blotting. Phosphorylation of mTOR
decreased upon treatment with HDL by more than 50%
(Figure 4C).
Electron microscopy revealed that HDL is taken up into
autophagosomes. The T84 cells were incubated with 8 nm
gold-labeled HDL for 18 hours and then ﬁxed and embedded
in Epon Araldite. Gold-labeled HDL was visible within ves-
icles resembling autophagosomes (the vesicles had typical
characteristics of engulfed cytoplasmic materials and or-
ganelles and were found in close proximity to organellesFigure 4. High-density
lipoprotein (HDL) induces
autophagy and is taken
up into autophagosomes.
(A) HDL increased auto-
phagy, demonstrated by an
increase in punctate stain-
ing for light chain 3 (LC3).
The cells were stained for
visualization of LC3 (green)
or cell nuclei (DAPI [blue]).
Scale bars: 25 mm. Repre-
sentative data from one of
four experiments is shown.
(B) HDL induced an in-
crease in conjugation of
LC3II during autophagy.
LC3 arbitrary units repre-
sent the ratio of LC3 to
actin normalized to the un-
treated controls. (C) HDL
decreased phosphorylation
of mammalian target of
rapamycin (p-mTOR), a
negative regulator of auto-
phagy. (D) HDL was taken
up into autophagosomes.
Electron microscopy shows
autophagic uptake of gold-
labeled HDL (arrows). (E)
HDL was found to coloc-
alize with LC3, conﬁrming a
possible autophagic uptake
of HDL into cells, Scale
bars: 25 mm.
Figure 4. (continued).
March 2015 Role of HDL Via IkB Kinase Autophagy 181that may represent lysosomes) (Figure 4D). Upon confocal
immunoﬂuorescence microscopy, HDL was found colo-
calized with LC3. The T84 cells were transduced with len-
tiviral constructs harboring GFP-LC3 and, after 24 hours,
were incubated with ﬂuorescently labeled HDL (Atto_655
HDL) for 18 hours. The cells were then ﬁxed with 4% PFA,and the nuclei was stained with DAPI. Colocalization of HDL
with LC3 was clearly demonstrated, supporting our
conclusion of HDL uptake into autophagosomes of T84 cells
(Figure 4E).
Autophagy is necessary for an HDL-mediated anti-
inﬂammatory effect, which involves recruitment of p-IKK to
182 Gerster et al Cellular and Molecular Gastroenterology and Hepatology Vol. 1, No. 2the autophagosome. The anti-inﬂammatory effect mediated
by HDL was shown to be dependent on tubulin. The T84
cells were incubated with 5 mM colchicine (which binds
tubulin and blocks its polymerization) followed by HDL 100
mg/mL for 18 hours and TNF 25 ng/mL for 3 hours. The
addition of colchicine statistically signiﬁcantly reversed by
19% (P < .05) the anti-inﬂammatory effect mediated by
HDL on mRNA expression of TNF (Figure 5A).
The anti-inﬂammatory effect of HDL was also reversed
after the inhibition of autophagy. The T84 cells were
pretreated with the autophagy-speciﬁc class IIIFigure 5. Autophagy is necessary for a high-density lipopr
volves the recruitment of phosphorylated IkB kinase (p-IK
mediated by HDL on mRNA expression of TNF was tubulin depe
tubulin blocker). The mRNA expression of TNF was quantiﬁed
deviation (SD), n ¼ 3. (B) Inhibition of autophagy using the pho
autophagy-speciﬁc class III PI-3 kinase inhibitor 3-methyl aden
demonstrated by suppression of TNF-induced NF-kB-responsiv
3. (C) Inhibition of autophagy (with wortmannin and 3-MA) rever
suppression of TNF-induced mRNA expression of TNF). The m
bar represents the mean ± SD, n ¼ 3. (D) The anti-inﬂammato
phagosome fusion inhibitor baﬁlomycin A1. The mRNA expressi
the mean ± SD, n ¼ 3. (E) The siRNA knockdown of the autoph
The mRNA expression of LC3 and TNF was quantiﬁed relative
ﬁbroblasts harboring the ATG16L1 mutation, the anti-inﬂamm
expression of TNF was quantiﬁed relative to actin. Each bar repr
and LC3 in T84 cells. Scale bars: 25 mm.phosphatidylinositol-3 (PI-3) kinase inhibitor 3-methyl
adenine (3-MA) at a concentration of 10 nM or the PI-3 ki-
nase inhibitor wortmannin at a concentration of 25 nM for 6
hours. Twenty-four hours after being transfected with lucif-
erase constructs expressing NF-kB-responsive elements, the
cells were incubated with 100 mg/mL HDL for 18 hours and
then25ng/mLTNF for 6hours. The ability ofHDL to suppress
TNF-induced NF-kB-responsive promoter activity, as
analyzed by the use of a dual luciferase reporter assay, was
decreased in the presence of 3-MA (by 26%) andwortmannin
(33%) (Figure 5B).otein (HDL)-mediated anti-inﬂammatory effect, which in-
K) to the autophagosome. (A) The anti-inﬂammatory effect
ndent, as shown by incubation of T84 cells with colchicine (a
relative to actin. Each bar represents the mean ± standard
sphatidylinositol-3 (PI-3) kinase inhibitor wortmannin and the
ine (3-MA) reversed the anti-inﬂammatory effect of HDL (as
e promoter activity). Each bar represents the mean ± SD, n ¼
sed the anti-inﬂammatory effect of HDL (as demonstrated by
RNA expression of TNF was quantiﬁed relative to actin. Each
ry effect of HDL was decreased in the presence of the auto-
on of TNF was quantiﬁed relative to actin. Each bar represents
agy gene LC3 decreased the anti-inﬂammatory effect of HDL.
to actin. Each bar represents the mean ± SD, n ¼ 3. (F) In
atory effect mediated by HDL was reduced. The mRNA
esents the mean ± SD, n ¼ 3. (G) HDL colocalizes with p-IKK
Figure 5. (continued).
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184 Gerster et al Cellular and Molecular Gastroenterology and Hepatology Vol. 1, No. 2In a similar experiment, after incubation for 6 hours with
3-MA and wortmannin, the cells were incubated with
100 mg/mL HDL for 18 hours followed by 25 ng/mL TNF for
3 hours. The ability of HDL to suppress the TNF-induced
mRNA expression of TNF was signiﬁcantly reduced in the
presence of wortmannin and 3-MA (Figure 5C).
Further testing showed that the anti-inﬂammatory effect
of HDL is decreased in the presence of the autophagosome
fusion inhibitor baﬁlomycin A1. The T84 cells were pre-
treated with baﬁlomycin A1 100 nM (to inhibit autophagy)
before the addition of HDL for 18 hours and subsequently
25 ng/mL TNF for 3 hours. Pretreatment with baﬁlomycin
signiﬁcantly decreased the ability of HDL to suppress TNF-
induced mRNA expression of TNF by 31% (Figure 5D).
In addition, siRNA knock down of the autophagy gene LC3
decreased the anti-inﬂammatory effect of HDL. The T84 cells
were transfected with 50 nM control siRNA or LC3 siRNA; 48
hours after transfection, the cells were incubated with 100
mg/mL HDL or 50 mg/mL apoA-I for 18 hours, before the
incubation with 25 ng/mL TNF for 3 hours. A 33% decrease
in LC3 expression was demonstrated (Figure 5E).
Genetic variants in autophagy genes ATG16L1 and
IRGM1 have been shown to increase the susceptibility to
CD.39–41 Cells expressing the variant ATG16L1 protein were
shown to have a defect in autophagy.35,42–45 To investigate
whether our ﬁnding is of relevance in humans, we isolated
mucosal ﬁbroblasts from CD patients with the ATG16L1
variant as well as WT patients. The anti-inﬂammatory effect
mediated by HDL was signiﬁcantly reduced in ﬁbroblasts
harboring the ATG16L1 mutation, which compromises
autophagocytic activity. Human mucosa-derived ﬁbroblasts
were preconditioned with or without HDL for 18 hours,
before the incubation with 25 ng/mL TNF for 3 hours. TNF
stimulated mRNA expression of TNF more pronouncedly in
ﬁbroblasts with ATG16L1 mutations. The ability of HDL to
suppress TNF-induced mRNA expression of TNF was
signiﬁcantly reduced by 44% and 12% in ﬁbroblasts
with homozygous and heterozygous ATG16L1 mutations
as compared with control ﬁbroblasts (Figure 5F). These
results suggest that dysfunctional autophagy limits the
anti-inﬂammatory functionality of HDL in human cells car-
rying the IBD-associated ATG16L1 variant.
To further investigate the role of HDL in the NF-kB
pathway, whole cell protein from T84 cells was extracted
and treated with HDL for 18 hours in the presence or
absence of 25 ng/mL TNF. Immunoblotting showed that
TNF increased p-IKK levels by 46%, but this effect was
reduced by 70% in the presence of HDL (Figure 3E). To
elucidate the relationship between HDL-induced autophagy
and decreased NF-kB activation, a colocalization experiment
was performed. The T84 cells were transfected with lenti-
viral constructs of GFP-LC3; Twenty-four hours after
transfection, the cells were incubated with ﬂuorescently
labeled HDL (Atto_655 HDL) for 18 hours. The cells were
ﬁxed with 4% PFA and stained for p-IKK using Alexaﬂuor
594 and for nuclei by using DAPI. Colocalization of LC3 with
HDL and p-IKK was observed (Figure 5G), indicating that
HDL might speciﬁcally recruit p-IKK to autophagosomes for
degradation, resulting in a decreased inﬂammatoryresponse via the prevention of further NF-kB activation and
induction of cytokine expression.
These studies demonstrate that HDL and its major pro-
tein component apoA-I act in an anti-inﬂammatory manner
via induction of autophagy and subsequent recruitment of
p-IKK into autophagosomes. Traditionally, the many cyto-
protective and anti-inﬂammatory functions of HDL have
been related to the ability of HDL to regulate cellular
cholesterol homeostasis by mediating cholesterol efﬂux5,6,11
or to elicit signal transduction by the interaction with cell
surface receptors such as scavenger receptor class B type I
(SR-BI), sphingosine-1-phosphate receptors, or ectopic
b-ATPase.7,11 Our data suggest a third mechanism: endo-
cytosis into intracellular organelles for neutralization of
proinﬂammatory molecules. Endocytosis was previously
identiﬁed as crucial for the antibiotic activity of HDL toward
Trypanosoma brucei46 but appears to be also relevant for
the blockage of NF-kB signaling in epithelial cells. From the
clinical perspective, our ﬁndings provide additional ratio-
nales to target or mimic8 HDL for the treatment of inﬂam-
matory diseases such as IBD.Conclusions
IBD patients of both genders display dyslipidemia with
signiﬁcantly lower HDL cholesterol. Because HDL is a
negative acute phase reactant and because the intestine is
the second most important site of HDL production, low HDL
cholesterol has traditionally been interpreted to be the
consequence of IBD. Because HDL exerts many anti-
inﬂammatory activities on many cells including endothelial
cells, pancreatic b-cells, and leukocytes, we hypothesized
that HDL may also modulate intestinal inﬂammation.11,47–50
We found evidence for anti-inﬂammatory effects of HDL and
apoA-I in the intestine, both in vitro and in vivo.
The proinﬂammatory cytokine TNF alters the integrity of
epithelial and endothelial cell barriers and is a key mediator
of mucosal inﬂammation in both CD and ulcerative colitis. An
increased concentration of TNF has been found in the blood,
mucosa, and feces of CD patients.51 In several animal models
of IBD, genetic ablation or anti-TNF treatment result in
amelioration of mucosal inﬂammation. Furthermore, inﬂix-
imab, a monoclonal antibody against TNF has been effective
in clinical management of IBD.51,52–54We therefore used TNF
as a proinﬂammatory stimulator for our in vitro experiments.
Preincubation of colon carcinoma T84 cells with HDL or
apoA-I for 18 hours signiﬁcantly suppressed TNF triggered
mRNA expression of IL-8, ICAM, and TNF by inhibiting NF-kB
promoter activity as measured by relative luciferase activity
and NF-kB DNA binding activity by EMSA. These ﬁndings are
very similar to those previously made in experiments with
endothelial cells and vascular smooth muscle cells where
HDL was also found to reduce cytokine production and
adhesion molecule expression via inhibition of NF-kB.55–58
Importantly, the anti-inﬂammatory properties of HDL
and apoA-I could be reproduced in an animal model of
colitis. Upon DSS or TNBS treatment, the apoA-I KO
phenotype exhibited a more severe intestinal inﬂammation
compared with the WT mice, as indicated by increased
March 2015 Role of HDL Via IkB Kinase Autophagy 185mucosal damage upon both colonoscopy and histology,
shorter colon length, increased intestinal MPO activity, and
mRNA expression of TNF and ICAM. Conversely, apoA-I Tg
mice, which have elevated levels of HDL, were partially
protected from DSS/TNBS-induced mucosal damage, as
indicated by the less severe symptoms upon colonoscopy
and less severe increase in MPO activity. The functional
importance of the attenuated intestinal inﬂammation
in apoA-I Tg mice is highlighted by the fact that WT and
apoA-I KO mice but not apoA-I Tg mice lost body weight
with DSS/TNBS treatment. These observations are in very
good agreement with previous ﬁndings of Cuzzocrea et al,57
who showed that administration of reconstituted HDL
reduces intestinal inﬂammation in animals with splanchnic
artery occlusion shock or colitis induced by dinitrobenzene
sulfonic acid.
HDL and apoA-I have been increasingly recognized as a
part of innate immune system for their ability to bind and
neutralize the toxic effects of lipopolysaccharide, a bacterial
product that can activate Toll-like receptors and thereby
stimulate the secretion of cytokines.59 This function may be
of special importance in the control of barrier integrity, such
as in the vascular endothelium and the intestinal epithelium.
Increased LC3-II is an indicator of preautophagosome
formation. In our experiments, we observed increased pro-
cessing of LC3 in the presence of HDL. This correlated with a
decrease in phosphorylation of mTOR, a negative regulator of
autophagy. Chemical inhibition of the autophagic pathway
using wortmannin and 3-MA decreased the ability of HDL to
decrease TNF-induced NF-kB responsive promoter activity
as well as expression of TNFmRNA expression. Interestingly,
pretreatment of T84 cells with baﬁlomycin A1, which in-
hibits the late stages of autophagosome fusion to lysosomes,
also inhibited the suppressive effect mediated by HDL on
TNF-induced mRNA expression of TNF. The intracellular
transport of HDL seems to be tubulin mediated, as demon-
strated by the reverse effect of HDL when T84 cells were
incubated with colchicine, a tubulin blocker.
Whereas siRNA knockdown of LC3 signiﬁcantly
decreased the ability of HDL to suppress inﬂammation, siRNA
knock down of the HDL receptors SRB1 and ABCA1 did not
have any effect (data shown in Supplementary Figure 1). This
observation correlates well with our studies in human ﬁ-
broblasts harboring the ATG16L1 mutation. Further, we
observed the uptake of gold-labeled HDL in autophagosomes,
which clearly depicted engulfed organelles such as mito-
chondria and which were found in close proximity to lipid
droplets. The autophagic uptake of HDLwas conﬁrmed by the
colocalization of ﬂuorescently labeled HDL with LC3 in colon
carcinoma cells. In addition, we could colocalize p-IKK with
LC3 and HDL, indicating that HDL might speciﬁcally recruit
p-IKK to be degraded in autophagosomes.
These results give an initial indication that autophagy
might regulate inﬂammatory pathways in intestinal cells
and HDL might modulate inﬂammation via autophagy. In
fact, apoL1, a minor component of HDL, has been shown to
induce autophagy and modulate host immunity.60–63
Although Muller et al65 have provided evidence that HDL
may, in contrast, inhibit autophagy and endoplasmicreticulum stress induced by oxidized LDL in human micro-
vascular endothelial cells, this effect cannot be generalized,
taking into account the different cell model used and the fact
that an increase in autophagy, especially selective auto-
phagy, can have a positive effect in reducing cellular stress
by the removal of speciﬁc stress factors enabling cell sur-
vival64 but also can result in apoptosis and cellular death.65
Despite the complex crosstalk between autophagy,
apoptosis, and endoplasmic reticulum stress, increasing
evidence points to the association of dysfunctional auto-
phagy with the pathogenesis of IBD. Genetic variation and
dysfunction in the autophagy genes IRGM and ATG16L1
have been implicated in improper bacterial handling and
abnormalities in Paneth cells.39 Scharl et al38 have published
an interesting study showing that PTPN2 maintains intes-
tinal barrier functions and limits the effects of proin-
ﬂammatory cytokines by up-regulating autophagy. This
study also shows that expression of autophagy proteins
ATG16L1, IRGM, LC3, and ATG5-ATG12 are signiﬁcantly
decreased in the inﬂamed mucosa of CD patients. Future
studies will be needed to determine whether the differences
found in our preclinical models reﬂect the situation in
macrophage and dendritic cell populations from patients
with different ATG16L1 polymorphisms. The innate immune
cells of patients with ATG16L1 polymorphisms will have to
be studied for their response to HDL to take our ﬁndings
into potential clinical application.
In summary, we report that HDL can decrease inﬂam-
mation by suppressing TNF-induced NF-kB responses
through the induction of autophagy. Chemical inhibition of
autophagy as well as knockdown of autophagy genes
decreased the ability of HDL to suppress inﬂammation in
colon carcinoma cells. Immunoﬂuorescence experiments
also showed that HDL recruits p-IKK, a key component of
the NF-kB pathway, to autophagosomes where they might
be degraded, thereby decreasing NF-kB activation. Present
day therapy of IBD consists of salicylates, corticosteroids,
and immunosuppressants, most of which cause severe side
effects. The clinical exploitation of HDL could be signiﬁcant
for the treatment of inﬂammatory diseases such as IBD.
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Supplementary
Figure 1. The siRNA me-
diated knock down of the
HDL receptors SRB1 and
ABCA1 as well as ABCG1
did not have a signiﬁcant
effect on HDL mediated
suppression of TNF
mRNA induction by TNF
stimulation. The mRNA
expression of TNF, SRB1,
ABCA1, and ABCG1 was
quantiﬁed relative to actin.
Each bar represents the
mean ± SD, n ¼ 3.
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